- Home
- LGND vs WLY Comparison
LGND vs WLY Comparison
Compare LGND & WLY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LGND
- WLY
- Stock Information
- Founded
- LGND 1987
- WLY 1807
- Country
- LGND United States
- WLY United States
- Employees
- LGND N/A
- WLY N/A
- Industry
- LGND Biotechnology: Pharmaceutical Preparations
- WLY Books
- Sector
- LGND Health Care
- WLY Consumer Discretionary
- Exchange
- LGND Nasdaq
- WLY Nasdaq
- Market Cap
- LGND 2.0B
- WLY 2.1B
- IPO Year
- LGND 1992
- WLY N/A
- Fundamental
- Price
- LGND $114.07
- WLY $43.38
- Analyst Decision
- LGND Strong Buy
- WLY
- Analyst Count
- LGND 8
- WLY 0
- Target Price
- LGND $144.71
- WLY N/A
- AVG Volume (30 Days)
- LGND 116.0K
- WLY 479.4K
- Earning Date
- LGND 08-05-2025
- WLY 06-17-2025
- Dividend Yield
- LGND N/A
- WLY 3.24%
- EPS Growth
- LGND N/A
- WLY N/A
- EPS
- LGND N/A
- WLY 1.53
- Revenue
- LGND $181,488,000.00
- WLY $1,677,609,000.00
- Revenue This Year
- LGND $18.41
- WLY N/A
- Revenue Next Year
- LGND $18.87
- WLY $1.13
- P/E Ratio
- LGND N/A
- WLY $28.42
- Revenue Growth
- LGND 53.40
- WLY N/A
- 52 Week Low
- LGND $77.53
- WLY $36.50
- 52 Week High
- LGND $129.90
- WLY $53.96
- Technical
- Relative Strength Index (RSI)
- LGND 62.44
- WLY 63.99
- Support Level
- LGND $111.88
- WLY $36.50
- Resistance Level
- LGND $116.16
- WLY $39.87
- Average True Range (ATR)
- LGND 3.58
- WLY 1.23
- MACD
- LGND 0.89
- WLY 0.60
- Stochastic Oscillator
- LGND 85.19
- WLY 89.35
About LGND Ligand Pharmaceuticals Incorporated
Ligand Pharmaceuticals Inc is a biopharmaceutical company focused on developing and acquiring technologies that aid in creating medicine. The company has partnerships and license agreements with various pharmaceutical and biotechnology companies. Ligand's business model is based on drug discovery, early-stage drug development, product reformulation, and partnerships. The company's revenue consists of three primary elements: royalties from commercialized products, license and milestone payments, and sale of its trademarked Captisol material.
About WLY John Wiley & Sons Inc.
John Wiley & Sons Inc is one of the world's greatest publishers and a trusted leader in research and learning. Its industry-principal content, services, platforms, and knowledge networks are tailored to meet the evolving needs of its customers and partners, including researchers, students, instructors, professionals, institutions, and corporations. The company empowers knowledge-seekers to transform today's obstacles into tomorrow's brightest opportunities. For more than two centuries, the company has been delivering on its timeless mission to unlock human potential.